Plexus director Rapp converts 1,370 RSUs to stock

Plexus Corp. director Karen Marie Rapp reported the vesting of equity awards and the corresponding issuance of common shares.

Accepted by SEC EDGAR 02/05/2026 - 04:18 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Plexus Corp. director Karen Marie Rapp reported the vesting of equity awards and the corresponding issuance of common shares. On February 3, 2026, 1,370 Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of Plexus common stock at an exercise price of $0.00 per share. Following this conversion, she directly beneficially owned 9,035 shares of Plexus common stock.

Insider Trade Summary

1,370 shares exercised/converted

Exercise 2 txns

Insider Rapp Karen Marie

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,370	$0.00	$0.00
Exercise	Common Stock, $.01 par value	1,370	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock, $.01 par value — 9,035 shares (Direct)

Holdings Before and After: Restricted Stock Units, 1,370 to 0 contracts (Direct); Common Stock, $.01 par value, 7,665 to 9,035 shares (Direct)

Footnotes (1)

1. F1. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Plexus Corp (PLXS) report for Karen Rapp?

Plexus Corp director Karen Marie Rapp reported the vesting of 1,370 Restricted Stock Units into 1,370 shares of common stock. The transaction, dated February 3, 2026, reflects equity compensation settling in stock rather than a market purchase or sale.

How many Plexus (PLXS) shares does Karen Rapp own after this Form 4?

After the reported transaction, Karen Marie Rapp directly beneficially owned 9,035 shares of Plexus common stock. This figure reflects her holdings following the vesting and settlement of 1,370 Restricted Stock Units into Plexus common shares on February 3, 2026.

What happened to Karen Rapp’s Restricted Stock Units at Plexus (PLXS)?

1,370 Restricted Stock Units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled on February 3, 2026. Each unit represented a contingent right to receive one share of Plexus common stock, and after settlement, zero Restricted Stock Units remained beneficially owned.

What does transaction code “M” mean in the Plexus (PLXS) Form 4?

Transaction code “M” on the Form 4 indicates an exercise or conversion of derivative securities. In this case, 1,370 Restricted Stock Units were converted into 1,370 shares of Plexus common stock as part of equity compensation vesting, at an exercise price of $0.00 per share.

Was the Plexus (PLXS) insider transaction a direct or indirect holding for Karen Rapp?

The Form 4 shows Karen Marie Rapp’s holdings as directly owned. After the vesting and settlement of 1,370 Restricted Stock Units into common stock, she directly beneficially owned 9,035 shares, with no indication of indirect ownership through another entity in the provided disclosure.

Under which plan were Karen Rapp’s Plexus (PLXS) Restricted Stock Units granted?

The Restricted Stock Units were granted under the Plexus Corp. 2024 Omnibus Incentive Plan. The footnote explains that each unit represented a contingent right to receive one share of Plexus common stock and that these units vested and settled on February 3, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rapp Karen Marie

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WI 54956

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value	02/03/2026		M		1,370	A	(1)	9,035	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/03/2026		M			1,370	(1)	(1)	Common Stock, $.01 par value	1,370	(1)	0	D

Explanation of Responses:

1. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

Remarks:

	/s/ Karen Rapp, by Kate A. Gitter, Attorney-in-Fact	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.